A PHASE III, RANDOMIZED, DOUBLE-BLIND STUDY OF BEVACIZUMAB, CARBOPLATIN, AND PACLITAXEL OR PEMETREXED WITH OR WITHOUT ATEZOLIZUMAB IN CHEMOTHERAPY-NAIVE PATIENTS WITH STAGE IV NON-SQUAMOUS NON-SMALL CELL LUNG CANCER (IMpower151)
| Title | A PHASE III, RANDOMIZED, DOUBLE-BLIND STUDY OF BEVACIZUMAB, CARBOPLATIN, AND PACLITAXEL OR PEMETREXED WITH OR WITHOUT ATEZOLIZUMAB IN CHEMOTHERAPY-NAIVE PATIENTS WITH STAGE IV NON-SQUAMOUS NON-SMALL CELL LUNG CANCER (IMpower151) |
|---|---|
| Description | RNA-seq molecular subtypes and gene experssion signatures in the phase 3 IMpower151 China study of 1L becacizumab + pemetrexed/paclitaxel ± atezolizumab in metastatic NSCLC |
| Organism | Homo sapiens |
| Data Type | Biomarker Data |
| Data Accessibility | Controlled-access |
| BioProject | PRJCA022297 |
| Release Date | 2024-04-05 |
| Submitter | ling zhang (shfkgcp@163.com) |
| Organization | shanghai pulmonary hospital |
| Submission Date | 2023-12-22 |
HTTP download speed may be slow. It is highly recommended that you download the dataset using a dedicated FTP tool (such as FileZilla Client).
| File ID | File Title | Number/Samples | File Type | File Size | File Suffix | Download Times | Download |
|---|---|---|---|---|---|---|---|
| OMIX005444-01 | YO30157_RNAseq result Dat | 3 | Biomarker Data | 260.19 MB | zip | 0 | Controlled |
| OMIX005444-02 | YO30157_ EGFR result data | 1 | Biomarker Data | 36.72 KB | zip | 0 | Controlled |